Rothschild Investment LLC’s Sana Biotechnology SANA Stock Holding History

Rothschild Investment LLC’s Portfolio SANA Stock Details SANA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$893	Sell	310 -14	-4%	-$55	﹤0.01%	2923
2025 Q4	$1.32K	Buy	324 +14	+5%	+$63	﹤0.01%	2566
2025 Q3	$1.1K	Hold	310	–	–	﹤0.01%	2533
2025 Q2	$846	Sell	310 -320	-51%	-$660	﹤0.01%	2558
2025 Q1	$1.06K	Buy	630 +270	+75%	+$755	﹤0.01%	2305
2024 Q4	$587	Buy	360 +140	+64%	+$417	﹤0.01%	2471
2024 Q3	$915	Buy	220 +150	+214%	+$788	﹤0.01%	2231
2024 Q2	$382	Buy	70 +55	+367%	+$438	﹤0.01%	2179
2024 Q1	$150	Buy	+15	New	+$112	﹤0.01%	1907

Other funds holding SANA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Marex Group London $15.8B AUM 31.44% 1-Year Est. Return

IHAM

Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return

Rothschild Investment LLC's SANA Position: Q1 2026 in Review

Rothschild Investment LLC reduced its Sana Biotechnology (SANA) stake by 4.3% in Q1 2026, selling an estimated $55 and leaving 310 shares worth $893. The position accounts for ﹤0.01% of the portfolio, ranked #2923.

Rothschild Investment LLC first reported a position in SANA in Q1 2024 and has held it in 9 quarters since. The position peaked at $1.32K in Q4 2025. 202 funds tracked by Wall St. Rank hold SANA as of Q1 2026.

Rothschild Investment LLC held 310 shares of Sana Biotechnology worth $893 as of Q1 2026.
Rothschild Investment LLC sold 14 Sana Biotechnology shares in Q1 2026, an estimated $55.
Sana Biotechnology made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q1 2026, its #2923 holding.
Rothschild Investment LLC first reported a position in Sana Biotechnology in Q1 2024 and has held it in 9 quarters since.
Rothschild Investment LLC's Sana Biotechnology position peaked at $1.32K in Q4 2025.
202 funds tracked by Wall St. Rank held Sana Biotechnology as of Q1 2026.

Based on Rothschild Investment LLC's 13F filing for Q1 2026, filed 7 May 2026.